On April 18, 2025, Canada's federal health authority, Health Canada, issued a recall warning affecting two medications due to concerns regarding incorrect dosing instructions. The recall was triggered to ensure the safety and well-being of consumers who might be using these products.

The first recalled product is the Life Brand Timed Release Melatonin 10mg. According to the news release from Health Canada, this product was found to have incorrect dosing instructions on its labeling. Consumers using this medication should be cautious and verify the details related to the proper dosing to avoid potential health risks. The specific affected lot numbers for this product are 4D3965YA2, 4F4495YA2, 4F44961B0, 4F44962LH, 4H49262LH, and 5C47764ES. Health Canada emphasized the importance of ensuring that individuals have access to accurate information regarding dosing.

The second product that has been recalled is Riva Acetaminophen 500mg, which is associated with potential dosing errors as well. The lot number impacted by this recall is D3120. Health Canada indicated that this particular lot might contain tablets that have an incorrect dosage of 325 milligrams of the active ingredient, posing further risks to consumers unaware of the discrepancies.

Health Canada underscored that the recalled products were distributed nationally, increasing the scope of potential exposure among Canadian consumers. In light of the recalls, the health authority advises that individuals should not discontinue use of any of the affected products without first consulting their health-care providers. This step is crucial for ensuring proper health management and addressing any concerns that may arise from using the recalled medications.

Furthermore, Health Canada encourages consumers to report any side effects they experience related to the use of the recalled products. This reporting is vital for monitoring the impact of the recalls and assists in improving drug safety and efficacy in the future.

In summary, the recalls of Life Brand Timed Release Melatonin 10mg and Riva Acetaminophen 500mg highlight ongoing efforts by Health Canada to prioritize public health safety regarding medication usage. Consumers are urged to remain vigilant and informed about the products they are using, especially when recalls occur, and to communicate with healthcare professionals about any concerns or adverse reactions they may experience.